Related Experiment Video
Updated: May 20, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
[Probiotics in the treatment of functional intestinal diseases]
Objective:
to evaluate the clinical effectiveness of biocomplexes "Normoflorin L, B" in the treatment of functional bowel disease with constipation syndrome. The study involved 30 patients with functional bowel disease (Rome criteria III, 2006), with irritable bowel syndrome with predominance of constipatio--16 people with functional constipation--14 people. The criteria of efficacy were: the dynamics of clinical symptoms, bacteriological examination of feces before and after treatment, intestinal transit time of Activated Charcoa- "carbolen" test the definition of short-chain fatty acids (SFA) in the feces by gas-liquid chromatography before and after treatment. The results of the study. In Normoflorin therapy there comes normalization of intestinal motor activity; positive changes in colon ecosystem, consisting of changes of methabolic activity of colonic microflora and its generic composition, normalization of anaerobic-aerobic relations, restoration of intracavitary redox potential of the luminal environment; eliminating the symptoms of intestinal dyspepsia (rumbling, flatulence). Bio-complexes Normofloriny are characterized by good tolerability and safety. The positive effect of "aftereffect" of drugs persists for at least 2 weeks. These data allow us to recommend the use of bio-complexes Normofloriny in treatment of functional bowel disease. These data allow to recommend the use of bio-complexes Normofloriny in treatment of functional bowel disease.
More Related Videos
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Probiotics
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Functions of the Gut Microbiota
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...